King's College London

Research portal

Staging of Burkitt's lymphoma and response to treatment monitored by PET scanning

Research output: Contribution to journalArticle

Original languageUndefined/Unknown
Pages (from-to)334-335
Number of pages2
JournalClinical Oncology
Issue number5
Publication statusPublished - 1995

Bibliographical note

M1 - 5

King's Authors


Positron emission tomography (PET) is an imaging technique using biological tracers (18-fluorine fluorodeoxyglucose (FDG)), whose uptake into tumour cells is increased. Previous studies carried out in patients with lymphoma have shown that PET is an accurate method of staging disease and that a high pre-treatment FDG uptake that is abolished by the end of chemotherapy is associated with a good clinical response. This case report demonstrates that clinical PET scanning can be especially useful in staging patients with lymphoma in whom there is extensive extranodal and marrow involvement, and that PET can follow changes in tumour viability over a very short time span.

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454